Relationship between the serum CA-125 level and bone mineral density in healthy pre- and post-menopausal women

被引:3
作者
Ahn, Ki Hoon [1 ]
Park, Hyun Tae [1 ]
Kim, Tak [1 ]
Hur, Jun Young [1 ]
Kim, Young Tae [1 ]
Lee, Kyu Wan [1 ]
Kim, Sun Haeng [1 ]
机构
[1] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea
关键词
bone mineral density; carbohydrate antigen-125; pre- and post-menopausal women; HORMONE REPLACEMENT THERAPY; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; TUMOR-MARKERS; EXPRESSION;
D O I
10.1111/j.1479-828X.2010.01183.x
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Background: Osteoporosis and tumour-associated antigen (TAA) levels are associated with inflammatory processes, but little remains known about TAA levels and bone mineral density (BMD). Aims: We determined whether or not high-normal TAA levels are associated with a lower BMD in healthy women. Methods: A total of 3769 healthy women were enrolled from the health screening programme over 5 years. Each participant had undergone a basic health examination. Serum carbohydrate antigen (CA)-125, CA-19-9, carcinoembryonic antigen (CEA) and alpha-fetoprotein levels were evaluated as tumour markers. The correlations between serum TAA levels and BMD were analysed. Results: Carbohydrate antigen 125 and CEA levels were positively associated with a higher BMD in the pre-menopause. In the post-menopause, the CA-125 level was positively associated with BMD. In the pre-menopause, CA-125 (r = 0.102; P < 0.001) and CEA levels (r = 0.134; P < 0.001) had a significant correlation with BMD. In the post-menopause, CA-125 was negatively associated with alkaline phosphatase (r = -0.298; P < 0.001). Conclusions: There was a significant positive association between CA-125 and BMD in healthy women. Additional basic and clinical studies on the relationship between CA-125 and bone are needed.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 17 条
[1]
Osteoimmunology - Bone versus immune system [J].
Arron, JR ;
Choi, Y .
NATURE, 2000, 408 (6812) :535-536
[2]
WHAT DO WE KNOW ABOUT THE ORIGIN OF CA-125 [J].
BISCHOF, P .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2) :93-98
[3]
Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy [J].
Cecchi, E. ;
Lapi, F. ;
Vannacci, A. ;
Banchelli, G. ;
Mazzei, T. ;
Mugelli, A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) :129-132
[4]
Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women [J].
Cengiz, B ;
Atabekoglu, C ;
Cetinkaya, E ;
Cengiz, SD .
MATURITAS, 2003, 46 (04) :301-306
[5]
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen [J].
Khosla, S ;
Melton, LJ ;
Atkinson, EJ ;
O'Fallon, WM ;
Klee, GG ;
Riggs, BL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2266-2274
[6]
Kimura Kyoto, 1995, Journal of Dermatology (Tokyo), V22, P28
[7]
Cytokine imbalance in non-immunological chronic disease [J].
Müller, B .
CYTOKINE, 2002, 18 (06) :334-339
[8]
Relationships among serum receptor of nuclear factor-κB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory [J].
Nabipour, Iraj ;
Larijani, Bagher ;
Vahdat, Katayoun ;
Assadi, Majid ;
Jafari, Seyed Mojtaba ;
Ahmadi, Esmaeil ;
Movahed, Ali ;
Moradhaseli, Farzad ;
Sanjdideh, Zahra ;
Obeidi, Narges ;
Amiri, Zahra .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (05) :950-955
[9]
IMMUNOHISTOCHEMISTRY OF CARCINOEMBRYONIC ANTIGEN IN THE EMBRYO, FETUS AND ADULT [J].
NAP, M ;
MOLLGARD, K ;
BURTIN, P ;
FLEUREN, GJ .
TUMOR BIOLOGY, 1988, 9 (2-3) :145-153
[10]
NAP M, 1992, CANCER RES, V52, P2329